Christopher Frankenfield

Christopher Frankenfield

Chief Operating Officer en XILIO THERAPEUTICS, INC. .

Fortuna: - $ al 31/03/2024

42 años
Health Technology
Consumer Services
Commercial Services

Perfil

Christopher Frankenfield is currently the Chief Operating Officer at Xilio Therapeutics, Inc. He previously worked as a Senior Associate at Wilmer Cutler Pickering Hale & Dorr LLP and as a Vice President-Corporate & Legal Affairs at Blueprint Medicines Corp.
He completed his undergraduate degree at The College of William & Mary and his graduate degree at the University of Virginia School of Law.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
01/01/2024 0 ( -.--% ) - $ 31/03/2024

Cargos activos de Christopher Frankenfield

Antiguos cargos conocidos de Christopher Frankenfield.

EmpresasCargoFin
Corporate Officer/Principal -
BLUEPRINT MEDICINES CORPORATION General Counsel -
Ver el detalle de la experiencia de Christopher Frankenfield.

Formación de Christopher Frankenfield.

The College of William & Mary Undergraduate Degree
University of Virginia School of Law Graduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Christopher Frankenfield.

Relaciones

28

Relaciones de 1er grado

5

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas2
BLUEPRINT MEDICINES CORPORATION

Health Technology

XILIO THERAPEUTICS, INC.

Health Technology

Empresas privadas1

Commercial Services

Ver las conexiones de la empresa
  1. Bolsa de valores
  2. Insiders
  3. Christopher Frankenfield